Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Proceedings of Spie--The International Society for Optical Engineering|September 2, 2022
Epidermal growth factor-targeted fluorescence is unaffected by standard neoadjuvant therapies in human sarcomasEric R Henderson, Paul Werth, Xiaochun Xu, et al.
Proceedings of Spie--The International Society for Optical Engineering|June 29, 2021
A paired-agent fluorescent molecular imaging strategy for quantifying antibody drug target engagement in <i>in vivo</i> window chamber xenograft modelsElif Kayaalp Nalbant, Cody Rounds, Negar Sadeghipour, et al.
Proceedings of Spie--The International Society for Optical Engineering|August 16, 2024
Onward to Better Surgery - the Critical Need for Improved Ex Vivo Testing and Training MethodsEric R Henderson, Ryan Halter, Keith D Paulsen, et al.
Molecular Imaging and Biology|November 13, 2013
Tumor endothelial marker imaging in melanomas using dual-tracer fluorescence molecular imagingKenneth M Tichauer, Sophie J Deharvengt, Kimberley S Samkoe, et al.
Molecular Imaging and Biology|December 29, 2011
In vivo quantification of tumor receptor binding potential with dual-reporter molecular imagingKenneth M Tichauer, Kimberley S Samkoe, Kristian J Sexton, et al.
Nature Medicine|October 27, 2014
Microscopic lymph node tumor burden quantified by macroscopic dual-tracer molecular imagingKenneth M Tichauer, Kimberley S Samkoe, Jason R Gunn, et al.
Molecular Imaging and Biology|August 18, 2011
High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreasKimberley S Samkoe, Kristian Sexton, Kenneth M Tichauer, et al.
Journal of Biomedical Optics|December 24, 2017
Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excisionKimberley S Samkoe, Brent D Bates, Niki N Tselepidakis, et al.
Molecular Cancer Therapeutics|December 17, 2024
First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue SarcomasKimberley S Samkoe, Hira Shahzad Sardar, Jason R Gunn, et al.
Pageof 12